Combinational radiotherapy and chemotherapy compositions and methods

Details for Australian Patent Application No. 2004290465 (hide)

Owner Novogen Research Pty Ltd

Inventors Kelly, Graham Edmund; Brown, David

Agent Davies Collison Cave

Pub. Number AU-B-2004290465

PCT Pub. Number WO2005/049008

Priority 2003906386 19.11.03 AU

Filing date 19 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 11 March 2010

International Classifications

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/192 (2006.01)

A61K 31/235 (2006.01)

A61K 31/245 (2006.01)

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/404 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/4748 (2006.01) - forming part of bridged ring systems

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/049008 Priority application(s): WO2005/049008

11 March 2010 Application Accepted

  Published as AU-B-2004290465

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290466-The monitoring of vital signs and performance levels

2004290464-Method and composition for treatment or prophylaxis of amyloidosis disorders